Literature DB >> 32655194

β-Silyloxy Allylboronate Esters through an Aldehyde Borylation/Homologation Sequence.

Gillian F Meyer1, Maggie A Nistler1, Andrey V Samoshin1,2, Brennan D McManus1, Taylor A Thane1, Carl J Ferber1, Gregory W O'Neil2, Timothy B Clark1.   

Abstract

The areas of carbonyl borylation and the homologation of carbon-boron bonds have provided a number of fruitful methods in organic synthesis. Combining these approaches, the homologation of α-oxyboronate esters, provides pathways to access complex organoboronate esters stereoselectively. To this end, the homologation of α-silyloxyboronate esters with lithiated allyl chlorides to form β-silyloxy allylboronate esters is reported. Direct oxidation of the homologation products provides β-silyloxy allyl alcohols in good yield. The homologation provides a range of allylic alcohols, albeit with low diastereoselectivity.

Entities:  

Keywords:  Allyl Boronates; Diboration; Homologation; α-Oxyboronate Esters

Year:  2020        PMID: 32655194      PMCID: PMC7351078          DOI: 10.1016/j.tetlet.2020.152082

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  16 in total

1.  Approval summary for bortezomib for injection in the treatment of multiple myeloma.

Authors:  Peter F Bross; Robert Kane; Ann T Farrell; Sophia Abraham; Kimberly Benson; Margaret E Brower; Sean Bradley; Jogarao V Gobburu; Anwar Goheer; Shwu-Luan Lee; John Leighton; Cheng Yi Liang; Richard T Lostritto; William D McGuinn; David E Morse; Atiqur Rahman; Lilliam A Rosario; S Leigh Verbois; Grant Williams; Yong-Cheng Wang; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

2.  Direct Synthesis of Secondary Benzylic Alcohols Enabled by Photoredox/Ni Dual-Catalyzed Cross-Coupling.

Authors:  Rauful Alam; Gary A Molander
Journal:  J Org Chem       Date:  2017-11-27       Impact factor: 4.354

3.  Stereospecific cross-coupling of secondary organotrifluoroborates: potassium 1-(benzyloxy)alkyltrifluoroborates.

Authors:  Gary A Molander; Steven R Wisniewski
Journal:  J Am Chem Soc       Date:  2012-10-01       Impact factor: 15.419

Review 4.  Ixazomib for the treatment of multiple myeloma.

Authors:  Massimo Gentile; Massimo Offidani; Ernesto Vigna; Laura Corvatta; Anna Grazia Recchia; Lucio Morabito; Fortunato Morabito; Silvia Gentili
Journal:  Expert Opin Investig Drugs       Date:  2015-07-03       Impact factor: 6.206

5.  Synthesis of α-aminoboronic acids.

Authors:  Patricia Andrés; Gema Ballano; M Isabel Calaza; Carlos Cativiela
Journal:  Chem Soc Rev       Date:  2016-02-08       Impact factor: 54.564

6.  Copper(I)-catalyzed enantioselective nucleophilic borylation of aldehydes: an efficient route to enantiomerically enriched α-alkoxyorganoboronate esters.

Authors:  Koji Kubota; Eiji Yamamoto; Hajime Ito
Journal:  J Am Chem Soc       Date:  2014-12-29       Impact factor: 15.419

7.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.

Authors:  J Adams; M Behnke; S Chen; A A Cruickshank; L R Dick; L Grenier; J M Klunder; Y T Ma; L Plamondon; R L Stein
Journal:  Bioorg Med Chem Lett       Date:  1998-02-17       Impact factor: 2.823

Review 8.  alpha-Amido boronic acids: a synthetic challenge and their properties as serine protease inhibitors.

Authors:  Donald S Matteson
Journal:  Med Res Rev       Date:  2008-03       Impact factor: 12.944

9.  Facile formation of β-hydroxyboronate esters by a Cu-catalyzed diboration/Matteson homologation sequence.

Authors:  Cameron M Moore; Casey R Medina; Peter C Cannamela; Melissa L McIntosh; Carl J Ferber; Andrew J Roering; Timothy B Clark
Journal:  Org Lett       Date:  2014-11-20       Impact factor: 6.005

10.  Stereoselective formation of trisubstituted vinyl boronate esters by the acid-mediated elimination of α-hydroxyboronate esters.

Authors:  Weiye Guan; Alicia K Michael; Melissa L McIntosh; Liza Koren-Selfridge; John P Scott; Timothy B Clark
Journal:  J Org Chem       Date:  2014-07-14       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.